论文部分内容阅读
Recent studies have shown that reprogramming of cholesterol metabolism occurs in both tumor cells and immune cells.Therapeutic strategies to inhibit the cholesterol synthesis pathway also interfere with normal metabolic homeostasis and actions of immune c